Grant: CIHR Fellowship
Direct Payment
$100,000.00
Vitamin D Status and Risk of Ovarian Cancer
FY 2008-09
Summary
Cancer of the ovary is the leading cause of death among women with gynecological malignancies. Having children, birth control and breastfeeding are protective; however, the prevention through modifiable exposures (diet, lifestyle) is scarce. Evidence from experimental and ecological studies suggest that vitamin D may reduce ovarian cancer risk. We recently published the first population-based study indicating an inverse relationship between plasma vitamin D levels and risk of ovarian cancer that was limited to obese women. We have also shown that individual genetic variation in the vitamin D receptor gene (which mediates the effects of vitamin D) may also affect this relationship. More importantly, there have been no studies evaluating whether characteristics of the ovarian tumor (histology) or the timing of intake (adolescence, premenopause) play a role. Confirmation of these hypotheses will help identify subgroups of women that would most benefit from vitamin D supplementation. Thus, the goal of this project is to confirm if vitamin D is protective for ovarian cancer and to evaluate whether such an association is affected by other factors (genetics, obesity). To carry out these objectives, I will use risk factor information and biologic specimens collected from the Nurses' Health Study (NHS) and NHSII. These are two large studies of over 238,000 nurses that have been followed every two years since 1976 (NHS) and 1989 (NHSII) to collect information regarding diet, lifestyle and disease development. Since dietary vitamin D intake is not an accurate measure of vitamin D status, we have developed a model to predict vitamin D blood levels. Given that vitamin D levels can be increased by oral supplements, the findings from this study will have important implications considering the limited prevention options currently available. Confirming a role of vitamin D will permit stronger public health advice to decrease the occurrence of this highly lethal cancer.
Department
Program
CIHR Fellowship
Recipient
Location
Massachusetts, United States of America
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
179135
Name
Kotsopoulos Joanne
Region
Massachusetts
Country
United States of America
Orgtype
Research Institution
Instname2
Cancer Research
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Vitamin D Status and Risk of Ovarian Cancer
Programtype2
Fellowship Programs
Orgnameinp2
Direct Payment
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Biomarkers; Cohort Studies; Epidemiology; Gene-Enviroment Interactions; Ovarian Cancer; Prevention; Receptor Expression; Risk Factors; Single Nucleotide Polymorphisms; Vitamin D
Abstract
Cancer of the ovary is the leading cause of death among women with gynecological malignancies. Having children, birth control and breastfeeding are protective; however, the prevention through modifiable exposures (diet, lifestyle) is scarce. Evidence from experimental and ecological studies suggest that vitamin D may reduce ovarian cancer risk. We recently published the first population-based study indicating an inverse relationship between plasma vitamin D levels and risk of ovarian cancer that was limited to obese women. We have also shown that individual genetic variation in the vitamin D receptor gene (which mediates the effects of vitamin D) may also affect this relationship. More importantly, there have been no studies evaluating whether characteristics of the ovarian tumor (histology) or the timing of intake (adolescence, premenopause) play a role. Confirmation of these hypotheses will help identify subgroups of women that would most benefit from vitamin D supplementation. Thus, the goal of this project is to confirm if vitamin D is protective for ovarian cancer and to evaluate whether such an association is affected by other factors (genetics, obesity). To carry out these objectives, I will use risk factor information and biologic specimens collected from the Nurses' Health Study (NHS) and NHSII. These are two large studies of over 238,000 nurses that have been followed every two years since 1976 (NHS) and 1989 (NHSII) to collect information regarding diet, lifestyle and disease development. Since dietary vitamin D intake is not an accurate measure of vitamin D status, we have developed a model to predict vitamin D blood levels. Given that vitamin D levels can be increased by oral supplements, the findings from this study will have important implications considering the limited prevention options currently available. Confirming a role of vitamin D will permit stronger public health advice to decrease the occurrence of this highly lethal cancer.
Competitiondate
200902
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Kotsopoulos, Joanne
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~